fructosamine has been researched along with Cardiovascular Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Chen, C; Gao, X; Gu, H; Kraus, VB; Li, C; Liu, Y; Lu, F; Lv, Y; Mao, C; Shi, X; Wang, J; Wei, Y; Yin, Z; Zhang, X; Zhao, F; Zhou, J | 1 |
| Abdel Hamid, DZ; Mostafa, TM; Nienaa, YA | 1 |
| Abdul-Ghani, M; Bergman, M; Bianchi, C; Buysschaert, M; Ceriello, A; Chung, S; Colette, C; Cravalho, C; DeFronzo, RA; Del Prato, S; Dorcely, B; Filipe Raposo, J; Fiorentino, TV; Ibrahim, N; Jagannathan, R; Macedo, MP; Manco, M; Medina, JL; Monnier, L; Monteiro, MP; Neves, JS; Owens, D; Phillips, LS; Rhee, M; Ribeiro, RT; Sesti, G | 1 |
| Enaya, MA; Kaftan, AN; Naser, FH | 1 |
| Bourdon, E; Cournot, M; Debussche, X; Guerin-Dubourg, A; Meilhac, O; Planesse, C; Rondeau, P | 1 |
| Kurl, S; Laukkanen, JA; Pitocco, D; Ronkainen, K; Zaccardi, F | 1 |
| Bergenstal, RM; Coresh, J; Grams, ME; Maruthur, NM; Parrinello, CM; Selvin, E; Sharrett, AR | 1 |
| Cummings, M; Kar, P; Laight, D; Rooprai, HK; Shaw, KM | 1 |
| Azenabor, A; Ogbera, OA; Okeoghene, OA | 1 |
| Coresh, J; Jaar, BG; Kim, ET; Parekh, RS; Plantinga, LC; Powe, NR; Selvin, E; Shafi, T; Sozio, SM; Steffes, MW | 1 |
| Dhindsa, P; Donnelly, R; Scott, AR | 1 |
| Gul, A; Rahman, MA | 2 |
| De Michele, G; Misciagna, G; Trevisan, M | 1 |
| Nagai, M; Sakata, K; Shirahama, S; Sueta, H; Tanaka, T; Yanagawa, H | 1 |
| Nagi, DK; Yudkin, JS | 1 |
| Chan, JC; Cockram, CS; Ko, GT; Woo, J | 1 |
| Browner, WS; Cummings, SR; Lui, LY; Pressman, AR | 1 |
| Anderson, RA; Bryden, NA; Bureau, I; Favier, M; Polansky, MM; Roussel, AM | 1 |
| al-Muhtaseb, N; al-Yusef, AR; Bajaj, JS | 1 |
| Arnetz, BB | 1 |
| Rahman, MA; Shera, AS; Zafar, G | 1 |
| Averna, M; Barbagallo, CM; Carroccio, A; Catalano, I; Davì, G; Giovenco, E; Notarbartolo, A; Strano, A | 1 |
2 review(s) available for fructosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Review of methods for detecting glycemic disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Intolerance; Glucose Metabolism Disorders; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Longitudinal Studies; Male; Middle Aged; Prediabetic State; Serum Albumin; Young Adult | 2020 |
Non enzymatic glycated proteins in the blood and cardiovascular disease.
Topics: Animals; Biomarkers; Blood Chemical Analysis; Blood Glucose; Cardiovascular Diseases; Fructosamine; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Humans; Lipoproteins, LDL; Risk Factors | 2007 |
4 trial(s) available for fructosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: a multi-center prospective randomized controlled study.
Topics: Anemia; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Erythropoietin; Fructosamine; Glycated Hemoglobin; Glycemic Control; Heart Disease Risk Factors; Humans; Iron; Prospective Studies; Renal Dialysis; Risk Factors; Thioctic Acid; Tumor Necrosis Factor-alpha; Urea | 2022 |
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
Topics: Biomarkers; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Pilot Projects; Serum Albumin; Serum Albumin, Human | 2017 |
Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Topics: Aged; Albuminuria; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Fructosamine; Grape Seed Extract; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Oxidative Stress; Photoplethysmography; Placebos; Risk Factors | 2009 |
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.
Topics: Albuminuria; Asia; Biomarkers; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Ethnicity; Fructosamine; Hexosamines; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Metabolic Clearance Rate; Metformin; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Triglycerides; United Kingdom; White People | 1993 |
17 other study(ies) available for fructosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Albumin-Corrected Fructosamine Predicts All-Cause and Non-CVD Mortality Among the Very Elderly Aged 80 Years or Older Without Diabetes.
Topics: Aged; Aged, 80 and over; Albumins; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Humans; Mortality; Prospective Studies; Risk Factors | 2022 |
Changes of Certain Metabolic and Cardiovascular Markers Fructosamine, H-FABP and Lipoprotein (a) in Patients with Hypothyroidism.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Fatty Acid Binding Protein 3; Female; Fructosamine; Healthy Volunteers; Humans; Hypothyroidism; Iraq; Lipoprotein(a); Male; Metabolic Diseases; Middle Aged | 2021 |
Serum fructosamine and risk of cardiovascular and all-cause mortality: a 24-year prospective population-based study.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Follow-Up Studies; Fructosamine; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Triglycerides | 2015 |
Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Racial Groups; Risk Factors; Serum Albumin | 2016 |
Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogens, Abnormal; Fructosamine; Glycated Hemoglobin; Humans; Lipoprotein(a); Male; Middle Aged; Nigeria; Risk Assessment; Statistics as Topic; Statistics, Nonparametric; Surveys and Questionnaires; Uric Acid | 2011 |
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Serum Albumin | 2013 |
Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Fructosamine; Humans; Male; Middle Aged; Obesity; Time Factors; Treatment Outcome | 2003 |
Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
Topics: Blood Glucose; Blood Proteins; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycoproteins; Glycosylation; Hexosamines; Humans; Male; Middle Aged; Pakistan; Sialic Acids | 2003 |
Antioxidant status in diabetic and non-diabetic senile patients, with cataract or cardiovascular complications.
Topics: Age Factors; Aged; Antioxidants; Blood Glucose; Blood Proteins; Cardiovascular Diseases; Cataract; Diabetes Complications; Female; Fructosamine; Glycated Hemoglobin; Humans; Male; Middle Aged | 2008 |
[Prevalence estimates for non-insulin dependent diabetes mellitus (NIDDM) in Japan from National Survey of Circulatory Disorders 1990 data].
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Health Surveys; Hexosamines; Humans; Japan; Male; Middle Aged; National Health Programs; Prevalence | 1994 |
Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; China; Diabetes Mellitus; Female; Fructosamine; Glucose Intolerance; Glucose Tolerance Test; Hong Kong; Humans; Male; Middle Aged; Practice Guidelines as Topic; Prevalence; Risk Factors; United States; Voluntary Health Agencies | 1998 |
Association between serum fructosamine and mortality in elderly women: the study of osteoporotic fractures.
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Diabetes Mellitus; Female; Follow-Up Studies; Fructosamine; Geriatric Assessment; Humans; Mortality; Multivariate Analysis; Risk Factors; Surveys and Questionnaires | 1999 |
Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women.
Topics: Administration, Oral; Blood Glucose; Cardiovascular Diseases; Cholesterol, LDL; Chromium; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Drug Administration Schedule; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Fructosamine; Humans; Hydrocortisone; Insulin; Leptin; Middle Aged; Postmenopause; Reference Values | 2002 |
Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
Topics: Adolescent; Adult; Age Factors; Apolipoproteins; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kuwait; Lipids; Lipoproteins; Risk Factors; Triglycerides | 1991 |
White collar stress: what studies of physicians can teach us.
Topics: Blood Pressure; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Fructosamine; General Surgery; Hexosamines; Humans; Male; Occupational Health; Odds Ratio; Physicians; Physicians, Family; Psychiatric Status Rating Scales; Risk Factors; Stress, Psychological; Sweden | 1991 |
Changes in glycosylated proteins in long-term complications of diabetes mellitus.
Topics: Adult; Cardiovascular Diseases; Cataract; Diabetes Complications; Diabetes Mellitus; Fructosamine; Glycosylation; Hexosamines; Humans; Middle Aged; Peripheral Nervous System Diseases; Proteins; Retinal Diseases | 1990 |
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control.
Topics: Adult; Apolipoproteins; Biomarkers; Blood Glucose; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; In Vitro Techniques; Insulin; Lipoproteins, HDL; Male; Middle Aged; Platelet Aggregation; Thromboxane B2 | 1989 |